Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 8563/PFP1112-13 | Other Grant/Funding Number | Northern Norway Regional Health Authority (Helse Nord RHF) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Royal Norwegian Ministry of Health | OTHER |
| Regionsenter for barn og unges psykiske helse | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background: There is need for more effectiveness studies concerning treatment of emotional symptom problems indicating anxiety and depression in adolescents. SMART is the only treatment manual for combined emotional disorders developed in Norwegian.
Purpose: To find the best individualized treatment for adolescents with emotional difficulties by: Finding criteria for the selection of appropriate patients for treatment with cognitive-behavior therapy program SMART in an outpatient population (14-18 years). Finding predictors of completion of treatment program SMART. Examining the effects of treatment with the SMART program at 6 months follow-up.
Design: A randomized controlled study in six outpatient clinics in the north of Norway. N= 160 referred adolescents (14-18 years) with score above 6 on the Emotional Problems scale of the Strength and Difficulties Questionnaire (SDQ). Two thirds are treated according to the SMART-manual immediately, while the waiting list control group is treated with SMART after six weeks.
Hypothesis: The SMART treatment is an effective treatment for emotional symptom problems.
Publication: The results sought published internationally and nationally and will be communicated to clinicians.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Waiting list control group | No Intervention | 6 week waiting list | |
| Individual cognitive behavioral therapy with SMART | Experimental | SMART manual cognitive behavioral therapy individual weekly sessions for 6 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SMART manual cognitive behavioral therapy | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Status of primary emotional disorder based on theDevelopment and Well-Being Assessment (DAWBA) interview schedule with parents and youths | Diagnostic interview | At recruitment, before treatment start and at 6 months follow up |
| Measure | Description | Time Frame |
|---|---|---|
| SDQ Strengths and Difficulties Questionnaire | Measure of general emotional and behavioral symptoms and strengths | At recruitment, before treatment start and at 6 months follow up |
| Anxiety symptom score on the Multi-Dimensional Anxiety Scale for Children (MASC) |
Not provided
Inclusion Criteria:
Age 14 to 18 years Referred to Community Mental Health Clinic for Children and Adolescents
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ingunn Skre, PhD | UiT Arctic University of Norway | Principal Investigator |
| Simon-Peter Neumer, Dr philos | Regionsenter for barn og unges psykiske helse, Sør-Øst | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital of North Norway | Tromsø | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35791020 | Derived | Lorentzen V, Fagermo K, Handegard BH, Neumer SP, Skre I. Long-term effectiveness and trajectories of change after treatment with SMART, a transdiagnostic CBT for adolescents with emotional problems. BMC Psychol. 2022 Jul 5;10(1):167. doi: 10.1186/s40359-022-00872-y. | |
| 32171328 | Derived | Lorentzen V, Fagermo K, Handegard BH, Skre I, Neumer SP. A randomized controlled trial of a six-session cognitive behavioral treatment of emotional disorders in adolescents 14-17 years old in child and adolescent mental health services (CAMHS). BMC Psychol. 2020 Mar 14;8(1):25. doi: 10.1186/s40359-020-0393-x. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000098647 | Generalized Anxiety Disorder |
| D000072861 | Phobia, Social |
| D000379 | Agoraphobia |
| D003863 | Depression |
| D016584 | Panic Disorder |
| ID | Term |
|---|---|
| D001008 | Anxiety Disorders |
| D001523 | Mental Disorders |
| D010698 | Phobic Disorders |
| D001526 | Behavioral Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Measure of anxiety symptoms |
| At recruitment, before treatment start and at 6 months follow up |
| Depression symptom status as measured by the self-rating instrument Beck Depression Inventory (BDI-II) | Measure of depressive symptoms | At recruitment, before treatment start and at 6 months follow up |
| Life functioning as measured by the rating scale C-GAS rated by clinicians | Measure of functioning | At recruitment, before treatment start and at 6 months follow up |
| General outcome measured by Clinical Outcomes in Routine Evaluations Outcome Measure (CORE-OM) | Measure of symptoms, risk, functioning and total burden of disorder | At recruitment, before treatment start and at 6 months follow up. The short version (CORE 10) mid-therapy: 3 weeks after starting treatment |
| D001519 |
| Behavior |